Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
Holding AVIR?
Track your performance easily
Atea Pharmaceuticals (AVIR) Ownership Overview
11.90% Insiders
14.38% Mutual Funds
8.98% Other Institutional Investors
11.34% ETFs
53.41% Public Companies and
Individual Investors
The ownership structure of Atea Pharmaceuticals (AVIR) stock is a mix of institutional, retail, and individual investors. Approximately 34.70% of the company’s stock is owned by Institutional Investors, 11.90% is owned by Insiders, and 53.41% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 21, 2024 | Bruce Polsky Director | xxxxxxxxxxxxx | $61053 |
| Jun 07, 2024 | Jean Pierre Sommadossi President, Ceo, And Chairman,director | xxxxxxxxxxxxx | $4024 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,162,914 | Insider | 9.60% | 27,427,391 | |
| 4,262,823 | Institution | 5.05% | 14,323,085 | |
| 3,797,568 | Institution | 4.50% | 12,759,828 | |
| 3,576,266 | Institution | 4.23% | 12,016,254 | |
| 1,811,377 | Institution | 2.14% | 6,086,227 | |
| 958,300 | Institution | 1.13% | 3,219,888 | |
| 876,763 | Institution | 1.04% | 2,945,924 | |
| 869,276 | Institution | 1.03% | 2,920,767 | |
| 811,867 | Institution | 0.96% | 2,727,873 | |
| 811,503 | Insider | 0.96% | 2,726,650 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,576,266 | Institution | 4.23% | 12,016,254 | |
| 1,811,377 | Institution | 2.14% | 6,086,227 | |
| 958,300 | Institution | 1.13% | 3,219,888 | |
| 876,763 | Institution | 1.04% | 2,945,924 | |
| 869,276 | Institution | 1.03% | 2,920,767 | |
| 811,867 | Institution | 0.96% | 2,727,873 | |
| 549,380 | Institution | 0.65% | 1,845,917 | |
| 502,608 | Institution | 0.60% | 1,688,763 | |
| 376,458 | Institution | 0.45% | 1,264,899 | |
| 342,681 | Institution | 0.41% | 1,151,408 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,363,327 | Institution | 2.80% | 7,917,145 | |
| 2,104,143 | Institution | 2.49% | 7,069,920 | |
| 1,275,767 | Institution | 1.51% | 4,273,819 | |
| 745,692 | Institution | 0.88% | 2,505,525 | |
| 511,688 | Institution | 0.61% | 1,719,272 | |
| 386,846 | Institution | 0.46% | 1,353,961 | |
| 354,688 | Institution | 0.42% | 1,188,205 | |
| 210,652 | Institution | 0.25% | 705,684 | |
| 174,928 | Institution | 0.21% | 587,758 | |
| 171,626 | Institution | 0.20% | 576,663 |
FAQ
Who Owns Atea Pharmaceuticals (AVIR)?
According to the latest TipRanks data, approximately 8.98% of the company's stock is held by institutional investors, 11.90% is held by insiders, and 53.41% is held by retail investors.
What percentage of Atea Pharmaceuticals (AVIR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 8.98% of Atea Pharmaceuticals (AVIR) stock is held by institutional investors.
What percentage of Atea Pharmaceuticals (AVIR) stock is held by retail investors?
According to the latest TipRanks data, approximately 53.41% of Atea Pharmaceuticals (AVIR) stock is held by retail investors.
Who owns the most shares of Atea Pharmaceuticals (AVIR)?
Jean-Pierre Sommadossi owns the most shares of Atea Pharmaceuticals (AVIR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.